JPMorgan Dad Turns Biotech CEO in Disease Quest

Feb. 20 (Bloomberg) -- Ilan Ganot, founder of Solid Ventures, talks about his decision to leave his career to create the biotechnology company after his son, Eytani, was diagnosed with Duchenne muscular dystrophy, a fatal genetic disease. Ganot, a former hedge fund specialist at JPMorgan Chase & Co., now aims to tackle the disease with a strategy he calls condition focus, a sole concentration on DMD. (Source: Bloomberg)
Does Apple TV Need a Revamp?
56:28 - Homebrew VC Partner Hunter Walk, Technalysis Founder Bob O’Donnell and IDC Chief Research Officer Crawford Del Prete discuss Apple to unveil a new TV box this fall and the future of Apple’s streaming service. They speak with Bloomberg’s Emily Chang on “Bloomberg West.” (Source: Bloomberg)
  • Why Would Microsoft Invest in Uber?
  • Why U.S. Wage Growth Has Screeched to a Halt
  • The China Slowdown Felt Around the World